Yellow fever vaccine: A successful vaccination of an immunocompromised patient

European Journal of Haematology

Volumn 72, Issue 4, 2004, Pages 299-301

  Gowda, R ^a   Cartwright, K ^a   Bremner, J A G ^a   Green, S T ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Immunodeficiency; Myeloma; Vaccine; Yellow fever

Indexed keywords

LIVE VACCINE; YELLOW FEVER VACCINE;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; HUMAN; IMMUNE DEFICIENCY; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; VACCINATION;

ANTIBODIES, VIRAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; HUMANS; IMMUNOCOMPROMISED HOST; KENYA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; TRAVEL; VACCINES, ATTENUATED; YELLOW FEVER VACCINE; YELLOW FEVER VIRUS;

EID: 1642565301     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2004.00218.x     Document Type: Article

References (10)

1. TOMORI O. Impact of yellow fever on the developing world. Adv Virus Res 1999;53:5-34.
2. VAINIO J, COUTTS F. Yellow Fever. Geneva: WHO, 1998.
3. VASCONCELOS PF, LUNA EJ, GALLER R, et al. Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases. Lancet 2001;358:91-97.
4. HUFF CA, JONES RJ. Bone marrow transplantation for multiple myeloma: where we are today. Curr Opin Oncol 2002;14:147-151.
5. CONE L, UHR JW. Immunological deficiency disorders associated with chronic lymphocytic leukemia and multiple myeloma. J Clin Invest 1964;43:2241-2248.
6. RECEVEUR MC, THIEBAUT R, VEDY S, MALVY D, MERCIE P, BRAS ML. Yellow fever vaccination of human immunodeficiency virus infected patients: report of 2 cases. Clin Infect Dis 2000;31:e7-e8.
7. KENGSAKUL K, SATHIRAPONGSASUTI K, PUNYAGUPTA S. Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection. J Med Assoc Thai 2002;85:131-134.
8. Department of Health, London. Indications and Contra-indications. Immunisation Against Infectious Disease, Chap. 7. London: Department of Health, 1996, ISBN 011321815X.
9. LJUNGMAN P. Immunisation of transplant recipients. Bone Marrow Transplant 1999;23:635-636.
10. Centers for Disease Control, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients. MMWR 2000;49(RR-10);1-128.